Literature DB >> 21278450

The role of RAD9 in tumorigenesis.

Howard B Lieberman1, Joshua D Bernstock, Constantinos G Broustas, Kevin M Hopkins, Corinne Leloup, Aiping Zhu.   

Abstract

RAD9 regulates multiple cellular processes that influence genomic integrity, and for at least some of its functions the protein acts as part of a heterotrimeric complex bound to HUS1 and RAD1 proteins. RAD9 participates in DNA repair, including base excision repair, homologous recombination repair and mismatch repair, multiple cell cycle phase checkpoints and apoptosis. In addition, functions including the transactivation of downstream target genes, immunoglobulin class switch recombination, as well as 3'-5' exonuclease activity have been reported. Aberrant RAD9 expression has been linked to breast, lung, thyroid, skin and prostate tumorigenesis, and a cause-effect relationship has been demonstrated for the latter two. Interestingly, human RAD9 overproduction correlates with prostate cancer whereas deletion of Mrad9, the corresponding mouse gene, in keratinocytes leads to skin cancer. These results reveal that RAD9 protein can function as an oncogene or tumor suppressor, and aberrantly high or low levels can have deleterious health consequences. It is not clear which of the many functions of RAD9 is critical for carcinogenesis, but several alternatives are considered herein and implications for the development of novel cancer therapies based on these findings are examined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278450      PMCID: PMC3107465          DOI: 10.1093/jmcb/mjq039

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  44 in total

1.  BRCT domain-containing protein TopBP1 functions in DNA replication and damage response.

Authors:  M Mäkiniemi; T Hillukkala; J Tuusa; K Reini; M Vaara; D Huang; H Pospiech; I Majuri; T Westerling; T P Mäkelä; J E Syväoja
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

2.  Rad9 is required for B cell proliferation and immunoglobulin class switch recombination.

Authors:  Lili An; Yulan Wang; Yuheng Liu; Xiao Yang; Chunchun Liu; Zhishang Hu; Wei He; Wenxia Song; Haiying Hang
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

3.  Physical interactions among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression.

Authors:  H Hang; H B Lieberman
Journal:  Genomics       Date:  2000-04-01       Impact factor: 5.736

4.  Retention of the human Rad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage.

Authors:  M A Burtelow; S H Kaufmann; L M Karnitz
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

5.  A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex.

Authors:  Itaru Hirai; Hong-Gang Wang
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

6.  Human DNA damage checkpoint protein hRAD9 is a 3' to 5' exonuclease.

Authors:  T Bessho; A Sancar
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

7.  The J domain of Tpr2 regulates its interaction with the proapoptotic and cell-cycle checkpoint protein, Rad9.

Authors:  S L Xiang; T Kumano; S I Iwasaki; X Sun; K Yoshioka; K C Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2001-10-05       Impact factor: 3.575

8.  Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition.

Authors:  Deborah A Greer Card; Megan L Sierant; Scott Davey
Journal:  J Biol Chem       Date:  2010-03-21       Impact factor: 5.157

9.  Dynamics of notch expression during murine prostate development and tumorigenesis.

Authors:  J Shou; S Ross; H Koeppen; F J de Sauvage; W Q Gao
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

10.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

View more
  27 in total

Review 1.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

2.  Combined haploinsufficiency and genetic control of the G2/M checkpoint in irradiated cells.

Authors:  Erik F Young; Lubomir B Smilenov; Howard B Lieberman; Eric J Hall
Journal:  Radiat Res       Date:  2012-05-18       Impact factor: 2.841

3.  RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

4.  mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.

Authors:  E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

5.  Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.

Authors:  Constantinos G Broustas; Aiping Zhu; Howard B Lieberman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

6.  RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2).

Authors:  Constantinos G Broustas; Kevin M Hopkins; Sunil K Panigrahi; Li Wang; Renu K Virk; Howard B Lieberman
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

7.  Repair complexes of FEN1 endonuclease, DNA, and Rad9-Hus1-Rad1 are distinguished from their PCNA counterparts by functionally important stability.

Authors:  Jordi Querol-Audí; Chunli Yan; Xiaojun Xu; Susan E Tsutakawa; Miaw-Sheue Tsai; John A Tainer; Priscilla K Cooper; Eva Nogales; Ivaylo Ivanov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

8.  Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.

Authors:  Marsha D Wallace; Adam D Pfefferle; Lishuang Shen; Adrian J McNairn; Ethan G Cerami; Barbara L Fallon; Vera D Rinaldi; Teresa L Southard; Charles M Perou; John C Schimenti
Journal:  Genetics       Date:  2012-07-30       Impact factor: 4.562

9.  Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.

Authors:  Sharon Ronald; Sanket Awate; Abhijit Rath; Jennifer Carroll; Floyd Galiano; Donard Dwyer; Heather Kleiner-Hancock; J Michael Mathis; Simone Vigod; Arrigo De Benedetti
Journal:  Genes Cancer       Date:  2013-01

10.  DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.

Authors:  Aiping Zhu; Kevin M Hopkins; Richard A Friedman; Joshua D Bernstock; Constantinos G Broustas; Howard B Lieberman
Journal:  Carcinogenesis       Date:  2021-02-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.